ENTRY       D12222                      Drug
NAME        Linvoseltamab (USAN)
FORMULA     C6455H9955N1721O2039S47
EXACT_MASS  145708.5068
MOL_WEIGHT  145798.4735
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFTFS NFWMTWVRQA PGKGLEWVAN MNQDGSEKYY
            VDSVKGRFTI SRDNAKSSLY LQMNSLRAED TAVYYCARDR EYCISTSCYD DFDYWGQGTL
            TVSSASTKG PSVFPLAPCS RSTSESTAAL GCLVKDYFPE PVTVSWNSGA LTSGVHTFPA
            LQSSGLYSL SSVVTVPSSS LGTKTYTCNV DHKPSNTKVD KRVESKYGPP CPPCPAPPVA
            GPSVFLFPPK PKDTLMISRT PEVTCVVVDV SQEDPEVQFN WYVDGVEVHN AKTKPREEQF
            NSTYRVVSVL TVLHQDWLNG KEYKCKVSNK GLPSSIEKTI SKAKGQPREP QVYTLPPSQE
            EMTKNQVSLT CLVKGFYPSD IAVEWESNGQ PENNYKTTPP VLDSDGSFFL YSRLTVDKSR
            WQEGNVFSCS VMHEALHNHY TQKSLSLSLG K
            (heavy chain)
            EVQLVESGGG LVQPGRSLRL SCAASGFTFD DYSMHWVRQA PGKGLEWVSG ISWNSGSKGY
            ADSVKGRFTI SRDNAKNSLY LQMNSLRAED TALYYCAKYG SGYGKFYHYG LDVWGQGTTV
            TVSSASTKGP SVFPLAPCSR STSESTAALG CLVKDYFPEP VTVSWNSGAL TSGVHTFPAV
            LQSSGLYSLS SVVTVPSSSL GTKTYTCNVD HKPSNTKVDK RVESKYGPPC PPCPAPPVAG
            PSVFLFPPKP KDTLMISRTP EVTCVVVDVS QEDPEVQFNW YVDGVEVHNA KTKPREEQFN
            STYRVVSVLT VLHQDWLNGK EYKCKVSNKG LPSSIEKTIS KAKGQPREPQ VYTLPPSQEE
            MTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SRLTVDKSRW
            QEGNVFSCSV MHEALHNRFT QKSLSLSPGK
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCRASQSIS SYLNWYQQKP GKAPKLLIYA ASSLQSGVPS
            RFSGSGSGTD FTLTISSLQP EDFATYYCQQ SYSTPPITFG QGTRLEIKRT VAAPSVFIFP
            PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL
            TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
            (Disulfide bridge: H22-H96, H103-H108, H139-L215, H152-H208, H231-h230, H234-h233, H265-H325, H371-H429, h22-h96, h138-L'215, h151-h207, h264-h324, h370-h428, L23-L88, L135-H195, L723-L'88, L'135-L'195)
  TYPE      Peptide
EFFICACY    Anti-TNFRSF17 antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of plasma cell disorders
TARGET      TNFRSF17 (BCMA, CD269) [HSA:608] [KO:K05153]
  PATHWAY   hsa04060(608)  Cytokine-cytokine receptor interaction
            hsa04672(608)  Intestinal immune network for IgA production
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Tumor necrosis factor receptors
                TNFRSF17 (BCMA, CD269)
                 D12222  Linvoseltamab (USAN)
DBLINKS     CAS: 2408319-25-3
///
